Siren, L.L.C. Oric Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,007,575 shares of ORIC stock, worth $12.5 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
1,007,575
Previous 1,007,575
-0.0%
Holding current value
$12.5 Million
Previous $5.62 Billion
81.9%
% of portfolio
0.53%
Previous 0.32%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
149Shares Held
91.9MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$89.2 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$82.1 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$81.8 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$65.8 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$60.1 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $493M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...